Sunderland Joint Formulary
NHS Sunderland Clinical Commissioning Group
South Tyneside and Sunderland NHS Foundation Trust

 
back
6 Endocrine system


06-04-04 Gender dysphoria

Buserelin
Formulary

Nasal spray: 100 micrograms per spray; 336 dose spray (Suprefact®)
Nasal spray: 150 micrograms per spray; 268 dose spray (Suprecur®)

 

Gender Dysphoria (unlicensed indication) - please see Northern Region Gender Dysphoria Service guidelines for further information


Green + View adult BNF  View SPC online
Cyproterone Acetate
Formulary

Tablets: 50mg & 100mg

 

Gender Dysphoria (unlicensed indication) - please see Northern Region Gender Dysphoria Service guidelines for further information


Green + View adult BNF  View SPC online
Estradiol
Formulary

Tablets: 1 mg & 2 mg

Patches: Twice weekly matrix patches releasing approximately 25, 50, 75 & 100 microgram/24 hours

Gel: 0.5 mg & 1 mg sachets; 28 sachets (Sandrena®)
Gel: 0.06% (0.75 mg per actuation); 80 g pump (Oestrogel®)

 

Gender Dysphoria (unlicensed indication) - please see Northern Region Gender Dysphoria Service guidelines for further information


Green + View adult BNF  View SPC online
Finasteride
Formulary

Tablets: 5 mg

 

Gender Dysphoria (unlicensed indication) - please see Northern Region Gender Dysphoria Service guidelines for further information


Green + View adult BNF  View SPC online
Goserelin
Formulary

Implant: 3.6 mg & 20.8 mg

 

Gender Dysphoria (unlicensed indication) - please see Northern Region Gender Dysphoria Service guidelines for further information


Green + View adult BNF  View SPC online
Leuprorelin
Formulary

Injection: 3.75 mg & 11.25 mg

 

Gender Dysphoria (unlicensed indication) - please see Northern Region Gender Dysphoria Service guidelines for further information


Green + View adult BNF  View SPC online
Nafarelin
Restricted

Nasal spray: 200 micrograms per spray; 60 dose spray

 

Gender Dysphoria (unlicensed indication) - please see Northern Region Gender Dysphoria Service guidelines for further information


Restricted Drug Green + View adult BNF  View SPC online
Spironolactone
Formulary

Tablets: 25 mg & 100 mg

 

Gender Dysphoria (unlicensed indication) - please see Northern Region Gender Dysphoria Service guidelines for further information


Green + View adult BNF  View SPC online
Testosterone
Formulary

Gel: 23 mg/1.15 g (23 mg per actuation); 85.5 g (Testavan®)

Gel: 50 mg/5 g (50 mg per tube); 30 tubes (Testim®)

Gel: 16.2 mg/g (20.25 mg per actuation); 88 g (Testogel®)

Gel: 50 mg/5 g sachet; 30 sachets (Testogel®)

Gel: 20 mg/g (10 mg per actuation); 60 g (Tostran®)

 

Gender Dysphoria (unlicensed indication) - please see Northern Region Gender Dysphoria Service guidelines for further information


Green + View adult BNF  View SPC online
Testosterone enantate
Formulary

Ampoule: 250 mg/1 mL

 

Gender Dysphoria (unlicensed indication) - please see Northern Region Gender Dysphoria Service guidelines for further information


Green + View adult BNF  View SPC online
Testosterone esters
Formulary

Ampoule: 250 mg (as esters)/1 mL (Sustanon 250<sup>®</sup>)

 

Gender Dysphoria (unlicensed indication) - please see Northern Region Gender Dysphoria Service guidelines for further information


Green + View adult BNF  View SPC online
Testosterone undecanoate
Formulary

Injection: 1g in 4 mL (250 mg/mlL oily injection (Nebido®)

 

Gender Dysphoria (unlicensed indication) - please see Northern Region Gender Dysphoria Service guidelines for further information

The medication is only green plus when used for treatment of gender dysphoria.

For indications other than gender dysphoria please see 'Male sex hormones and antagonists - 06.04.02'


Green + View adult BNF  View SPC online
Triptorelin
Formulary

Injection: 3 mg, 3.75 mg, 11.25 mg and 22.5 mg

 

Gender Dysphoria (unlicensed indication) - please see Northern Region Gender Dysphoria Service guidelines for further information


Green + View adult BNF  View SPC online